Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,020 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Decolonization in Nursing Homes to Prevent Infection and Hospitalization.
Miller LG, McKinnell JA, Singh RD, Gussin GM, Kleinman K, Saavedra R, Mendez J, Catuna TD, Felix J, Chang J, Heim L, Franco R, Tjoa T, Stone ND, Steinberg K, Beecham N, Montgomery J, Walters D, Park S, Tam S, Gohil SK, Robinson PA, Estevez M, Lewis B, Shimabukuro JA, Tchakalian G, Miner A, Torres C, Evans KD, Bittencourt CE, He J, Lee E, Nedelcu C, Lu J, Agrawal S, Sturdevant SG, Peterson E, Huang SS. Miller LG, et al. Among authors: montgomery j. N Engl J Med. 2023 Nov 9;389(19):1766-1777. doi: 10.1056/NEJMoa2215254. Epub 2023 Oct 10. N Engl J Med. 2023. PMID: 37815935 Clinical Trial.
HEMOLYTIC REACTION AFTER NOVOBIOCIN THERAPY.
MONTGOMERY JR. MONTGOMERY JR. N Engl J Med. 1963 Oct 31;269:966. doi: 10.1056/nejm196310312691808. N Engl J Med. 1963. PMID: 14056645 No abstract available.
Efficacy of Intravesical Nadofaragene Firadenovec for Patients with BCG-Unresponsive Non-muscle Invasive Bladder Cancer: 5 Year Follow-Up from a Phase 3 Trial.
Narayan VM, Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Mashni J Jr, Lane BR, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Inman BA, Williams MB, Cookson MS, Chang SS, Sankin AI, O'Donnell MA, Sawutz D, Philipson R, Parker NR, Yla-Herttuala S, Rehm D, Jakobsen JS, Juul K, Dinney CPN. Narayan VM, et al. Among authors: montgomery js. J Urol. 2024 May 5:101097JU0000000000004020. doi: 10.1097/JU.0000000000004020. Online ahead of print. J Urol. 2024. PMID: 38704840
Extragonadal Germ Cell Tumors: A Clinicopathologic Study with Emphasis on Molecular Features, Clinical Outcomes and Associated Secondary Malignancies.
Abdulfatah E, Brown NA, Davenport MS, Reichert ZR, Camelo-Piragua SI, Heider A, Huang T, Vaishampayan UN, Skala SL, Montgomery JS, Chinnaiyan AM, Kaffenberger S, Bawa P, Shao L, Mehra R. Abdulfatah E, et al. Among authors: montgomery js. Hum Pathol. 2024 Apr 30:S0046-8177(24)00082-0. doi: 10.1016/j.humpath.2024.04.015. Online ahead of print. Hum Pathol. 2024. PMID: 38697270
Detection of a Human Adenovirus Outbreak, Including Some Critical Infections, Using Multipathogen Testing at a Large University, September 2022-January 2023.
Montgomery JP, Marquez JL, Nord J, Stamper AR, Edwards EA, Valentini N, Frank CJ, Washer LL, Ernst RD, Park JI, Price D, Collins J, Smith-Jeffcoat SE, Hu F, Knox CL, Khan R, Lu X, Kirking HL, Hsu CH. Montgomery JP, et al. Open Forum Infect Dis. 2024 Apr 5;11(5):ofae192. doi: 10.1093/ofid/ofae192. eCollection 2024 May. Open Forum Infect Dis. 2024. PMID: 38680614 Free PMC article.
Overview of U.S. COVID-19 vaccine safety surveillance systems.
Gee J, Shimabukuro TT, Su JR, Shay D, Ryan M, Basavaraju SV, Broder KR, Clark M, Buddy Creech C, Cunningham F, Goddard K, Guy H, Edwards KM, Forshee R, Hamburger T, Hause AM, Klein NP, Kracalik I, Lamer C, Loran DA, McNeil MM, Montgomery J, Moro P, Myers TR, Olson C, Oster ME, Sharma AJ, Schupbach R, Weintraub E, Whitehead B, Anderson S. Gee J, et al. Among authors: montgomery j. Vaccine. 2024 Apr 16:S0264-410X(24)00224-X. doi: 10.1016/j.vaccine.2024.02.065. Online ahead of print. Vaccine. 2024. PMID: 38631952 Free article.
Urinary bother, Urinalysis, and Two-Year Efficacy Follow-Up Results of Phase I Trial of Intravesical Bacillus Calmette-Guérin Combined with Intravenous Pembrolizumab in Recurrent or Persistent High-Grade Non-Muscle-Invasive Bladder Cancer after Previous Bacillus Calmette-Guérin Treatment.
Montgomery J, Lybbert D, Sana S, El-Zawahry A, Peabody J, Pearce T, Adams N, Deebajah M, Dynda D, Babaian K, Crabtree J, Delfino K, McVary K, Robinson K, Rao K, Alanee S. Montgomery J, et al. Clin Genitourin Cancer. 2024 Feb 28;22(3):102059. doi: 10.1016/j.clgc.2024.02.010. Online ahead of print. Clin Genitourin Cancer. 2024. PMID: 38554570
2,020 results